Cyclacel Pharmaceuticals, Inc. (CYCC) Reports Q3 Loss of $0.37

Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) reported Q3 EPS of ($0.37), versus ($0.43) reported last year.

For earnings history and earnings-related data on Cyclacel Pharmaceuticals, Inc. (CYCC) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• DraftKings Inc. (DKNG) PT Lowered to $48 at UBS on Updated Estimates Post Q2
• Can global equities keep rising? UBS sees these factors driving upside